A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses.
about
Genetic polymorphism of merozoite surface protein-1 in Plasmodium falciparum isolates from patients with mild to severe malaria in Libreville, GabonAllelic dimorphism of the erythrocyte binding antigen-175 (eba-175) gene of Plasmodium falciparum and severe malaria: Significant association of the C-segment with fatal outcome in Ghanaian childrenRecombination hotspots and population structure in Plasmodium falciparumCytophilic antibodies to Plasmodium falciparum glutamate rich protein are associated with malaria protection in an area of holoendemic transmissionExpansion of Lysine-rich Repeats in Plasmodium Proteins Generates Novel Localisation Sequences that Target the Periphery of the Host ErythrocyteA systematic map of genetic variation in Plasmodium falciparumGenetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidatePatterns of genetic variation in populations of infectious agentsPopulation genomic scan for candidate signatures of balancing selection to guide antigen characterization in malaria parasites.Malaria burden and case management in the Republic of Congo: limited use and application of rapid diagnostic tests results.Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali.Linkage group selection: towards identifying genes controlling strain specific protective immunity in malaria.Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.Sequence conservation in Plasmodium falciparum alpha-helical coiled coil domains proposed for vaccine development.Population diversity and antibody selective pressure to Plasmodium falciparum MSP1 block2 locus in an African malaria-endemic settingFunctional memory B cells and long-lived plasma cells are generated after a single Plasmodium chabaudi infection in mice.The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.Lineage-specific positive selection at the merozoite surface protein 1 (msp1) locus of Plasmodium vivax and related simian malaria parasites.Genetic diversity of the Plasmodium vivax merozoite surface protein-5 locus from diverse geographic origins.Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparumGenome-wide analysis of selection on the malaria parasite Plasmodium falciparum in West African populations of differing infection endemicity.Competition between Plasmodium falciparum strains in clinical infections during in vitro culture adaptationPopulation genetic analysis of large sequence polymorphisms in Plasmodium falciparum blood-stage antigens.Schistosomiasis coinfection in children influences acquired immune response against Plasmodium falciparum malaria antigensA genetic approach to the de novo identification of targets of strain-specific immunity in malaria parasites.Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum field isolates from Myanmar.Evidence of gene conversion in genes encoding the Gal/GalNac lectin complex of Entamoeba.Strategies for designing and monitoring malaria vaccines targeting diverse antigensPlasmodium falciparum genotypes, low complexity of infection, and resistance to subsequent malaria in participants in the Asembo Bay Cohort ProjectA malaria vaccine based on the polymorphic block 2 region of MSP-1 that elicits a broad serotype-spanning immune responseQuantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humans.Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.Allele frequency-based and polymorphism-versus-divergence indices of balancing selection in a new filtered set of polymorphic genes in Plasmodium falciparum.The evolutionary genomics of pathogen recombination.Epitope-specific regulation of immunoglobulin class switching in mice immunized with malarial merozoite surface proteins.Immunogenicity of a synthetic vaccine based on Plasmodium vivax Duffy binding protein region II.Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malariaAnalysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum.Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogensLimited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.
P2860
Q22812992-379CD437-5F06-449D-A972-43C634286210Q24806782-007E3312-E6BA-479E-9B98-818D40DD4F3DQ24812792-702ED01B-F71B-44EA-B42B-215B138890A6Q24815535-C4A2E907-878C-4F58-BC3E-352DE5C11729Q27972793-A490F4B6-20CC-4B64-8B7C-6EE608BF58F1Q28469012-A186BDC7-6E7B-4CB3-9558-456EDC4D7835Q28748331-04C895C8-7082-4EB3-AA15-610794B05E2BQ30832656-BE4F38BC-EE8D-4F6B-9BCC-1FF7D3834450Q31076942-233FCA9B-595A-41C4-93A4-A475621AB259Q31111101-1E0920CF-CDF9-4DB3-90A6-9F33E5A3DB79Q33278087-0D311BFD-4437-4DC3-B9B7-8512B1E696ADQ33298592-D560791D-DF98-499A-9410-3948C4E17480Q33305467-010082EF-CE2C-455A-AD60-DAF6FF3D0A55Q33459259-1A6BF4E3-57A7-4ED9-B7D3-E4369478AEF5Q33510819-9FE76E9A-3D4C-4D74-BAAA-DDF3D6377A90Q33518486-F6DDB2F4-1E2D-457C-B52F-C06802627A7FQ33526349-A0FB3543-0127-477B-BB66-6724BEE68054Q33532314-C2EBC221-AF28-495A-A37B-8DB6900EDB1BQ33533686-59BD8D93-E2B6-4902-86D1-74503E593120Q33591313-A7A48882-597E-483C-B36A-D61782516F3FQ33654376-3E250221-6808-4D5A-AF65-72D7D2E9B166Q33680865-1869C8F3-0203-49C0-8469-7D387A4D274BQ33691419-F064BE38-3112-4989-9E45-31F3AB836124Q33697651-A1B3E253-9AA5-4084-AF02-76A761E80A48Q33756139-B8940587-C242-4D03-99B2-1C2C34EE9F78Q33884383-CCBD50CC-35F6-4872-8BCD-F094CA486E55Q33955418-9DE3C86B-D53F-4BA5-A148-7918C9C146A7Q33959038-861BC83D-06E2-4838-8C76-7A2B704A0DB1Q34009873-0AAC3331-BFED-459B-89FA-587E7143E9ACQ34071439-78358F11-1252-4524-AB22-BCA529D725B9Q34081745-9F71146E-C003-429E-A37F-6ADC8097585AQ34125960-9AC21198-7CDA-4A19-9DCD-47716B691F54Q34148387-F8F22409-AA8E-4B07-85DA-44AA90E741E9Q34168118-37DC75ED-741D-4622-A9F3-BAAAA2D1BCAAQ34194702-BB2B9D7D-2398-4CE1-AA52-7698B4F59975Q34260750-8F7BD76F-E079-4046-8B05-11849CE484FFQ34301187-619FA1F4-242E-4C47-BC1D-EA2059044065Q34334187-6F0E96ED-2CE8-415F-826D-4090C5EEA723Q34401573-C91DEA34-4E08-4583-B988-AE2A3D1E573CQ34416904-5DC800CC-9D7C-4E49-A36D-4F9B78889D54
P2860
A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
A principal target of human im ...... ic and immunological analyses.
@en
type
label
A principal target of human im ...... ic and immunological analyses.
@en
prefLabel
A principal target of human im ...... ic and immunological analyses.
@en
P2093
P2860
P50
P356
P1433
P1476
A principal target of human im ...... ic and immunological analyses.
@en
P2093
Cavanagh DR
McBride JS
Sakihama N
P2860
P2888
P304
P356
10.1038/76272
P407
P577
2000-06-01T00:00:00Z